Clal Biotechnology Industries Ltd (CBI) — Defensive Interval Ratio
Clal Biotechnology Industries Ltd (CBI) has a Defensive Interval Ratio of 9 days as of June 2025. Defensive assets of ILA463.00K (cash ILA-, short-term investments ILA-, receivables ILA463.00K) cover 9 days of daily cash needs of ILA49.45K/day. Check Clal Biotechnology Industries Ltd (CBI) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Clal Biotechnology Industries Ltd Defensive Interval Ratio (2007–2024)
This chart shows how Clal Biotechnology Industries Ltd's Defensive Interval Ratio has evolved across 18 annual periods from 2007 to 2024. As of June 2025, the ratio stands at 9 days, meaning defensive assets of ILA463.00K can fund 9 days of operations without new revenue. Also explore net asset momentum of Clal Biotechnology Industries Ltd to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Clal Biotechnology Industries Ltd (2007–2024)
The table below presents the year-by-year Defensive Interval Ratio for Clal Biotechnology Industries Ltd from 2007 to 2024, covering 18 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see CBI stock market capitalisation.
| Year | DIR (days) | Defensive Assets (ILA) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 29 days | ILA1.56 Million | ILA54.78K/day | ILA- | ILA1.06 Million | ▼ -417 days |
| 2023 | 446 days | ILA8.14 Million | ILA18.25K/day | ILA- | ILA7.63 Million | ▼ -736 days |
| 2022 | 1182 days | ILA9.43 Million | ILA7.98K/day | ILA- | ILA5.44 Million | ▲ +1095 days |
| 2021 | 87 days | ILA8.53 Million | ILA97.67K/day | ILA- | ILA- | ▼ -1580 days |
| 2020 | 1667 days | ILA129.15 Million | ILA77.48K/day | ILA- | ILA118.34 Million | ▲ +842 days |
| 2019 | 824 days | ILA92.73 Million | ILA112.47K/day | ILA- | ILA76.98 Million | ▼ -589 days |
| 2018 | 1414 days | ILA91.72 Million | ILA64.88K/day | ILA- | ILA63.40 Million | ▲ +1245 days |
| 2017 | 169 days | ILA14.44 Million | ILA85.43K/day | ILA- | ILA830.00K | ▲ +52 days |
| 2016 | 117 days | ILA21.81 Million | ILA187.06K/day | ILA- | ILA5.39 Million | ▼ -198 days |
| 2015 | 315 days | ILA57.59 Million | ILA182.97K/day | ILA- | ILA38.81 Million | ▼ -1069 days |
| 2014 | 1384 days | ILA240.40 Million | ILA173.72K/day | ILA- | ILA227.94 Million | ▲ +668 days |
| 2013 | 716 days | ILA100.02 Million | ILA139.64K/day | ILA- | ILA85.81 Million | ▼ -223 days |
| 2012 | 939 days | ILA114.28 Million | ILA121.70K/day | ILA- | ILA99.93 Million | ▼ -1165 days |
| 2011 | 2104 days | ILA199.68 Million | ILA94.88K/day | ILA- | ILA177.97 Million | ▲ +210 days |
| 2010 | 1894 days | ILA118.56 Million | ILA62.60K/day | ILA- | ILA118.56 Million | ▼ -189 days |
| 2009 | 2083 days | ILA110.34 Million | ILA52.97K/day | ILA- | ILA110.34 Million | ▲ +1901 days |
| 2008 | 182 days | ILA30.35 Million | ILA166.84K/day | ILA- | ILA26.18 Million | ▲ +145 days |
| 2007 | 36 days | ILA1.23 Million | ILA33.71K/day | ILA- | ILA1.23 Million | — |